TSC research including Research Round Up – a quarterly summary of some of the most important TSC-related research from Australia and around the world.
Epilepsy develops in 70-90% of children with TSC and it is often resistant to medication. This study investigated the potential benefits of early (preventive) treatment with vigabatrin to prevent TSC-related seizures.
In this first Research Round Up for 2021 we are delighted to feature three significant studies which Australian-based researchers have undertaken. Read more now
The aim of this study was to summarise the results of all available research addressing the factors associated with the development of autism spectrum disorder (ASD) in children with TSC. There were 42 suitable studies which included data for 3,542 children with TSC.
Epilepsy develops in 70-90% of children with TSC and it is often resistant to medication. This study investigated the potential benefits of early (preventive) treatment with vigabatrin to prevent TSC-related seizures.
Cannabidiol (CBD) is approved as Epidyolex in Australia. The aim of this study was to look at whether the addition of CBD to other epilepsy medications was successful in reducing the number of seizures associated with TSC.
The theme of this issue of Research Round Up is renal manifestations of TSC. We have summarised two recent, important research studies. We are also delighted to include a video interview with Dr Sean Kennedy, one of TSA’s medical advisors.
In this issue of Research Round Up we have included two very different research reports which we hope will be of interest to our TSC Community; Improving developmental abilities in infants with TSC and Multidisciplinary model of care for TSC adults in France.
